Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;23(12):619-27.
doi: 10.1016/j.tem.2012.05.012. Epub 2012 Jul 11.

Action of RORs and their ligands in (patho)physiology

Affiliations
Review

Action of RORs and their ligands in (patho)physiology

Laura A Solt et al. Trends Endocrinol Metab. 2012 Dec.

Abstract

The retinoic-acid-receptor-related orphan receptors (RORs) are members of the nuclear receptor (NR) superfamily whose activity has been implicated in several physiological and pathological processes. The RORs, specifically RORα and RORγ, are considered to be master regulators of T(H)17 cells, a recently described subset of CD4(+) T helper cells that have been demonstrated to have a pathological role in autoimmune disease. As with most members of the NR superfamily, RORs are ligand-regulated, suggesting that their activity can be modulated by synthetic ligands. Recent advances in the field have established that selective inhibition of the RORs is a viable therapeutic approach for not only the treatment of autoimmune disorders but also ROR-mediated metabolic disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1. ROR Regulation of the Circadian Rhythm
Circadian rhythms are biological processes that display endogenous oscillations of approximately 24 hours and are regulated by a core circadian clock. The master circadian clock is located in the suprachiasmatic nucleus (SCN) of the hypothalamus. There are several interconnected transcriptional auto-regulatory feedback loops controlling the circadian cycle. Heterodimers of BMAL1 and CLOCK activate the expression of CRY and PER genes. Once the CRY/PER heterodimers reaches a critical threshold, they enter the nucleus and repress BMAL/CLOCK transactivation. RORα and REV-ERBα have been demonstrated to positively or negatively regulate the expression of BMAL1, respectively. RORα competes with REV-ERBa for binding of their shared DNA response element in the BMAL1 promoter. The oscillating pattern of RORα and REVERBα in the SCN dictates the circadian pattern of of BMAL1 expression. This RORα/REV-ERBα feedback loops interconnects the positive and negative arms of the core circadian clock.
Figure 2
Figure 2. RORα and RORγ in TH17 Cell Differentiation
In the presence of several exogenous factors, including TGFβ, IL-6, and IL-1, naïve CD4+ T cells differentiate into TH17 cells. Exogenous IL-23 is necessary for the propagation of pathogenic TH17 cells. The expression of RORα and particularly RORγt is necessary for TH17 cell differentiation and for the expression of IL-17A and IL-17F, among other cytokines. TH17 cells play a significant role in host defense against extracellular pathogens at mucosal surfaces. However, aberrant TH17 cell activity has been associated with the pathology of several autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and psoriasis.
Figure 3
Figure 3. Regulation of ROR activity with synthetic ligands
The RORs are considered to have intrinsic transcriptional activity, meaning that they are constitutively active and bind coactivators in the absence of ligand. However, due to the ubiquitous expression of putative ROR ligands, it remains to be determined whether the RORs are ever in an unbound state or require ligand for receptor stability. Treatment with an agonist(SR1078) would result in the recruitment of more coactivator proteins, thereby enhancing transcriptional activity. Inverse agonists, when bound to the RORs LBD, induce a conformational change in the receptor resulting in dissociation of coactivator proteins and recruitment of corepressor proteins. Inverse agonists repress the activity of the receptors.

References

    1. Mangelsdorf DJ, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–9. - PMC - PubMed
    1. Hummasti S, Tontonoz P. Adopting new orphans into the family of metabolic regulators. Mol Endocrinol. 2008;22:1743–53. - PMC - PubMed
    1. Mohan R, Heyman RA. Orphan nuclear receptor modulators. Curr Top Med Chem. 2003;3:1637–47. - PubMed
    1. Giguere V, et al. Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 1994;8:538–53. - PubMed
    1. Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF, Becker-Andre M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol. 1994;8:757–70. - PubMed

MeSH terms

Substances